389621-83-4 Usage
Uses
Used in Organic Chemistry:
4-(Piperidine-1-carbonyl)phenylboronic acid is used as a key component in the Suzuki reaction for facilitating carbon-carbon bonding. This reaction is widely employed in the synthesis of various organic compounds, making it an essential tool in the field of organic chemistry.
Used in Pharmaceutical Industry:
4-(Piperidine-1-carbonyl)phenylboronic acid is used as a building block in the synthesis of pharmaceutical compounds. Its unique structure allows for the creation of new drug candidates with potential therapeutic applications.
Used in Material Science:
4-(Piperidine-1-carbonyl)phenylboronic acid is used as a precursor in the development of new materials with specific properties, such as improved conductivity or enhanced stability. Its versatility in chemical reactions makes it a valuable asset in material science research and development.
Used in Research and Development:
4-(Piperidine-1-carbonyl)phenylboronic acid is used as a research compound for exploring new chemical reactions and understanding the underlying mechanisms. Its role in the Suzuki reaction makes it a valuable tool for advancing knowledge in the field of organic chemistry and related disciplines.
Check Digit Verification of cas no
The CAS Registry Mumber 389621-83-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,9,6,2 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 389621-83:
(8*3)+(7*8)+(6*9)+(5*6)+(4*2)+(3*1)+(2*8)+(1*3)=194
194 % 10 = 4
So 389621-83-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H16BNO3/c15-12(14-8-2-1-3-9-14)10-4-6-11(7-5-10)13(16)17/h4-7,16-17H,1-3,8-9H2
389621-83-4Relevant articles and documents
INHIBITORS OF FATTY ACID AMIDE HYDROLASE
-
Page/Page column 210, (2008/12/05)
The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a ther
11β-HSD1 INHIBITORS
-
Page/Page column 28, (2008/06/13)
The invention relates to sulfonamide compounds of formula (I) wherein A, B, R1 and Xl to X3 have the meaning as cited in the description and the claims. For example A is biphenyl, B is 3-methoxyphenyl, Rl is H and Xl to X3 are CH. Said compounds are usefu
New phenylpyridylpiperazine compounds
-
Page/Page column 9, (2008/06/13)
A compound selected from those of formula (I): [image] wherein: X represents a C(O) or SO2 group, R1 represents an aryl group or a group NR3R4 wherein R3 and R4 are as defined in the description, R2 represents an alkyl, (C3-C8)cycloalkyl or (C3-C8)cycloalkyl-(C1-C6)alkyl group, its isomers, and addition salts thereof, and medicinal products containing the same which are useful in treating conditions treatable by antagonists of type H3 central histamine receptors.